FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to compounds of general formula 
in which R1 stands for C1-C4-alkyl; R2 stands for C1-C4-alkyl; R3 stands for phenyl, which optionally contains 1-3 any substituents, selected from the group, including halogen, C1-C6-alkyl and C1-C4-alkoxygroup; R4 stands for hydrogen; C1-C6-alkyl or C3-C7-cycloalkyl -C1-C4-alkyl, R5 stands for hydrogen; and R6stands for hydrogen; and R7 stands for hydrogen; and R9 stands for C1-C4-alkyl; and R10 stands for C1-C6-alkyl, phenyl-C0-C4-alkyl or pyridinyl-C0-C4-alkyl; on condition that R10 does not stand for phenyl, if R5 and R9 together form C2-alkylene; or R5 R9 together form C1-C3-alkylene; or R6 and R9 together form C1-C3-alkylene; or R7 and R9 together form C2-C4-alkylene or C1-C3-alkyleneoxygroup; or R8 and R9 together form C3-C5-alkylene; or R9 and R10 together form C4-C6-alkylene; and n equals 0 or 1, or its any physiologically compatible salts. In addition, the invention relates to pharmaceutical composition, containing formula I compounds and intended for treatment of cardio-vascular diseases, to application of said compounds for preparation of medication, as well as to method of obtaining formula I compounds.
EFFECT: obtained and described are novel compounds, possessing cardio-vascular activity.
16 cl, 8 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NEW ANTAGONISTS NK AND NK | 2006 |
|
RU2419609C2 |
| 4-AMINOPYPERIDINE DERIVATIVES | 2005 |
|
RU2396257C2 |
| 2,2-DIALKYL OR TRANS-2,2-DIALKYL-3,4-DIHYDRO-3-HYDROXY-6- (PYRIDIN-4-YL)-2H-1-BENZOPYRANS | 1992 |
|
RU2104277C1 |
| SULFONAMIDES AND PHARMACEUTICAL PREPARATION | 1995 |
|
RU2162084C2 |
| STEREOISOMER COMPOUNDS AND METHODS OF TREATING GASTROINTESTINAL DISORDERS AND CENTRAL NERVOUS SYSTEM DISORDERS | 2005 |
|
RU2374244C2 |
| BENZOPYRANES, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT | 1994 |
|
RU2122000C1 |
| MACROCYCLIC UREA AND SULPHAMIDE DERIVATIVES AS TAFIa INHIBITORS | 2009 |
|
RU2502736C2 |
| RETINOID COMPOUNDS, METHOD FOR THEIR PREPARING (VARIANTS), PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT OF RESPIRATORY WAY OBSTRUCTIVE DISEASE, CANCER OR DERMATOLOGICAL DISTURBANCE OF DISORDER | 2002 |
|
RU2275367C2 |
| CARPAPENEM DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | 1992 |
|
RU2091381C1 |
| PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
